Siemens Healthineers AG announced that changes in the Managing Board of the company. Michael Reitermann, currently responsible in the Board for the Diagnostics business segment as well as for the regional sales and service organization, will be stepping down by the end of fiscal year 2019. Christoph Zindel, who is currently heading the company's global Imaging business, will join the Board. In the Board, Christoph will be responsible for Imaging and Advanced Therapies. Bernhard montag will assume responsibility for the Diagnostics business at board level as well as the enterprise services and customer services business horizontals and for the company's 3 global regions. Michael will be leaving the Board in amicable agreement.